Abstract | OBJECTIVE: METHODS: RESULTS:
Pain and tenderness improved remarkably after teriparatide treatment for 1 month, and these symptoms disappeared after teriparatide treatment for 9 months. The patient also received raloxifen as further therapy, and the fracture line had completely disappeared by 15 months after treatment. CONCLUSIONS: Even though a previous study has reported that teriparatide healed stress fractures in a rat model and even with the time course of fracture healing in our patient, we are still not certain that teriparatide played a primary role in the positive response to therapy. Vitamin D therapy, calcium, and alendronate discontinuation may have played secondary roles. This case report may serve to introduce a direction for future research into the pharmacological treatment of atypical femoral fractures. Surgical treatment of incomplete atypical femoral fractures may be a safer method.
|
Authors | Hsuan-Ti Huang, Lin Kang, Peng-Ju Huang, Yin-Chih Fu, Sung-Yen Lin, Chih-Hsin Hsieh, Jian-Chih Chen, Yuh-Min Cheng, Chung-Hwan Chen |
Journal | Menopause (New York, N.Y.)
(Menopause)
Vol. 19
Issue 12
Pg. 1360-3
(Dec 2012)
ISSN: 1530-0374 [Electronic] United States |
PMID | 22968250
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Bone Density Conservation Agents
- Teriparatide
- Raloxifene Hydrochloride
- Alendronate
|
Topics |
- Alendronate
(administration & dosage, adverse effects)
- Bone Density Conservation Agents
(therapeutic use)
- Female
- Femoral Fractures
(diagnosis, drug therapy)
- Fractures, Stress
(diagnosis, drug therapy)
- Humans
- Middle Aged
- Osteoporosis, Postmenopausal
(drug therapy)
- Raloxifene Hydrochloride
(therapeutic use)
- Teriparatide
(therapeutic use)
|